RT @corporateeurope: 🤔 How did the EU move away from vaccines being available for everybody to treating them as a private monopoly?
🦠 @olivierhoedeman researcher at @corporateeurope , talks about what the European Parliament Committee has to answer and how CEO's own research is going
#tripswaiver